PRVA
Privia Health Group, Inc.$28.05+0.02 (+0.07%)Prev Close$28.03·MCap$3.46B·P/E167.25·Vol778.9K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
24
$20.01M
◆
Net Activity
Net Seller
$20.01M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Privia Health Group, Inc. (PRVA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 24 insider sales totaling $20.01M. The most recent insider transaction was by Mountcastle David (officer: EVP & Chief Financial Officer), who sold $588.7K worth of shares on Jul 13, 2026. Privia Health Group, Inc. operates in the Healthcare sector, within the Medical - Healthcare Information Services industry, with a market cap of $3.46B.
PRVA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 21,275 | $27.67 | $588.7K | 164,853 |
| Jul 9, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 600 | $27.57 | $16.5K | 186,128 |
| Jul 7, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 24,734 | $27.50 | $680.2K | 186,728 |
| Jul 7, 2026 | Morris Matthew Shawn | director | Sell | 112,759 | $27.29 | $3.08M | 76,651-60% |
| Jul 2, 2026 | Morris Matthew Shawn | director | Sell | 135,498 | $26.32 | $3.57M | 113,692-54% |
| Jun 30, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 17,196 | $25.18 | $433.0K | 211,462 |
| Jun 30, 2026 | Morris Matthew Shawn | director | Sell | 63,212 | $25.33 | $1.60M | 76,651-45% |
| May 13, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 3,385 | $22.60 | $76.5K | 211,462 |
| May 13, 2026 | Mehrotra Parth | director, officer: Chief Executive Officer | Sell | 121,086 | $22.56 | $2.73M | 450,004 |
| May 5, 2026 | Morris Matthew Shawn | director | Sell | 18,113 | $24.99 | $452.6K | 68,188 |
| May 5, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 8,385 | $25.03 | $209.8K | 214,847 |
| Apr 6, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 5,566 | $20.85 | $116.1K | 214,847 |
| Mar 18, 2026 | Mehrotra Parth | director, officer: Chief Executive Officer | Sell | 26,509 | $22.11 | $586.1K | 555,443 |
| Mar 18, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 6,391 | $22.11 | $141.3K | 220,413 |
| Mar 16, 2026 | Mehrotra Parth | director, officer: Chief Executive Officer | Sell | 53,992 | $21.71 | $1.17M | 609,181 |
| Mar 16, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 13,018 | $21.71 | $282.6K | 233,369 |
| Mar 12, 2026 | Mehrotra Parth | director, officer: Chief Executive Officer | Sell | 21,097 | $22.71 | $479.1K | 322,698 |
| Mar 10, 2026 | Fargis Edward C | officer: EVP & General Counsel | Sell | 9,343 | $22.99 | $214.8K | 88,660 |
| Mar 10, 2026 | Mehrotra Parth | director, officer: Chief Executive Officer | Sell | 63,439 | $22.95 | $1.46M | 385,794 |
| Mar 10, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 11,006 | $22.99 | $253.0K | 167,732 |
| Mar 2, 2026 | Morris Matthew Shawn | director | Sell | 24,338 | $25.00 | $608.4K | 68,188-26% |
| Mar 2, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 13,058 | $25.03 | $326.8K | 172,909 |
| Dec 12, 2025 | Morris Matthew Shawn | Director | Sell | 13,647 | $25.01 | $341.3K | 0 |
| Dec 12, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 23,887 | $25.03 | $597.9K | 0 |
| May 12, 2025 | Mehrotra Parth | Chief Executive Officer | Sell | 29,682 | $24.74 | $734.3K | 0 |
| May 12, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 3,322 | $24.99 | $83.0K | 0 |
| Apr 30, 2025 | Mehrotra Parth | Chief Executive Officer | Sell | 32,465 | $23.20 | $753.1K | 0 |
| Apr 30, 2025 | Morris Matthew Shawn | Director | Sell | 10,309 | $23.33 | $240.5K | 0 |
| Apr 30, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 3,445 | $23.33 | $80.4K | 0 |
| Apr 2, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 5,630 | $22.38 | $126.0K | 0 |
| Mar 12, 2025 | Mehrotra Parth | Chief Executive Officer | Sell | 10,514 | $24.03 | $252.7K | 0 |
| Mar 10, 2025 | Fargis Edward C | EVP & General Counsel | Sell | 4,967 | $24.21 | $120.3K | 0 |
| Mar 10, 2025 | Mehrotra Parth | Chief Executive Officer | Sell | 18,934 | $24.21 | $458.4K | 0 |
| Mar 10, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 5,851 | $24.21 | $141.7K | 0 |
| Feb 19, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 100,000 | $25.15 | $2.52M | 157,727-39% |
| Sep 12, 2024 | Mehrotra Parth | Chief Executive Officer | Sell | 135,142 | $18.50 | $2.50M | 247,771-35% |
| Jun 13, 2024 | Boehler Adam | Director | Buy | 364 | $16.50 | $6.0K | 5,773,522 |
| May 31, 2024 | Boehler Adam | Director | Buy | 5,306 | $16.50 | $87.5K | 5,773,158 |
| May 29, 2024 | Boehler Adam | Director | Buy | 4,280 | $16.49 | $70.6K | 5,767,852 |
| May 23, 2024 | Boehler Adam | Director | Buy | 552,436 | $16.25 | $8.98M | 5,763,572 |
| May 23, 2024 | McCarthy Thomas A | Director | Buy | 10,000 | $16.37 | $163.7K | 52,611 |
| May 13, 2024 | Bartrum Thomas | Sell | 1,506 | $17.88 | $26.9K | 102,356 | |
| May 13, 2024 | Mehrotra Parth | Chief Executive Officer | Sell | 13,869 | $17.88 | $248.0K | 247,771 |
| May 13, 2024 | Mountcastle David | EVP & Chief Financial Officer | Sell | 2,232 | $17.88 | $39.9K | 257,727 |
| May 2, 2024 | Bartrum Thomas | Sell | 2,252 | $18.42 | $41.5K | 103,862 | |
| May 2, 2024 | Mehrotra Parth | Chief Executive Officer | Sell | 12,219 | $18.42 | $225.1K | 261,640 |
| May 2, 2024 | Morris Matthew Shawn | Director | Sell | 11,059 | $18.42 | $203.7K | 70,101 |
| May 2, 2024 | Mountcastle David | EVP & Chief Financial Officer | Sell | 2,320 | $18.42 | $42.7K | 259,959 |
| Apr 4, 2024 | Mountcastle David | EVP & Chief Financial Officer | Sell | 3,933 | $17.77 | $69.9K | 262,279 |
| Mar 12, 2024 | Sullivan William M | Director | Sell | 7,515 | $23.03 | $173.1K | 5,445,418 |
Showing 1–50 of 198
1 / 4
PRVA Insider Buying Activity
The following table shows recent insider purchases of Privia Health Group, Inc. (PRVA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 13, 2024 | Boehler Adam | Director | Buy | 364 | $16.50 | $6.0K | 5,773,522 |
| May 31, 2024 | Boehler Adam | Director | Buy | 5,306 | $16.50 | $87.5K | 5,773,158 |
| May 29, 2024 | Boehler Adam | Director | Buy | 4,280 | $16.49 | $70.6K | 5,767,852 |
| May 23, 2024 | Boehler Adam | Director | Buy | 552,436 | $16.25 | $8.98M | 5,763,572 |
| May 23, 2024 | McCarthy Thomas A | Director | Buy | 10,000 | $16.37 | $163.7K | 52,611 |
PRVA Insider Selling Activity
The following table shows recent insider sales of Privia Health Group, Inc. (PRVA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 21,275 | $27.67 | $588.7K | 164,853 |
| Jul 9, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 600 | $27.57 | $16.5K | 186,128 |
| Jul 7, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 24,734 | $27.50 | $680.2K | 186,728 |
| Jul 7, 2026 | Morris Matthew Shawn | director | Sell | 112,759 | $27.29 | $3.08M | 76,651-60% |
| Jul 2, 2026 | Morris Matthew Shawn | director | Sell | 135,498 | $26.32 | $3.57M | 113,692-54% |
| Jun 30, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 17,196 | $25.18 | $433.0K | 211,462 |
| Jun 30, 2026 | Morris Matthew Shawn | director | Sell | 63,212 | $25.33 | $1.60M | 76,651-45% |
| May 13, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 3,385 | $22.60 | $76.5K | 211,462 |
| May 13, 2026 | Mehrotra Parth | director, officer: Chief Executive Officer | Sell | 121,086 | $22.56 | $2.73M | 450,004 |
| May 5, 2026 | Morris Matthew Shawn | director | Sell | 18,113 | $24.99 | $452.6K | 68,188 |
| May 5, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 8,385 | $25.03 | $209.8K | 214,847 |
| Apr 6, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 5,566 | $20.85 | $116.1K | 214,847 |
| Mar 18, 2026 | Mehrotra Parth | director, officer: Chief Executive Officer | Sell | 26,509 | $22.11 | $586.1K | 555,443 |
| Mar 18, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 6,391 | $22.11 | $141.3K | 220,413 |
| Mar 16, 2026 | Mehrotra Parth | director, officer: Chief Executive Officer | Sell | 53,992 | $21.71 | $1.17M | 609,181 |
| Mar 16, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 13,018 | $21.71 | $282.6K | 233,369 |
| Mar 12, 2026 | Mehrotra Parth | director, officer: Chief Executive Officer | Sell | 21,097 | $22.71 | $479.1K | 322,698 |
| Mar 10, 2026 | Fargis Edward C | officer: EVP & General Counsel | Sell | 9,343 | $22.99 | $214.8K | 88,660 |
| Mar 10, 2026 | Mehrotra Parth | director, officer: Chief Executive Officer | Sell | 63,439 | $22.95 | $1.46M | 385,794 |
| Mar 10, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 11,006 | $22.99 | $253.0K | 167,732 |
| Mar 2, 2026 | Morris Matthew Shawn | director | Sell | 24,338 | $25.00 | $608.4K | 68,188-26% |
| Mar 2, 2026 | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 13,058 | $25.03 | $326.8K | 172,909 |
| Dec 12, 2025 | Morris Matthew Shawn | Director | Sell | 13,647 | $25.01 | $341.3K | 0 |
| Dec 12, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 23,887 | $25.03 | $597.9K | 0 |
| May 12, 2025 | Mehrotra Parth | Chief Executive Officer | Sell | 29,682 | $24.74 | $734.3K | 0 |
| May 12, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 3,322 | $24.99 | $83.0K | 0 |
| Apr 30, 2025 | Mehrotra Parth | Chief Executive Officer | Sell | 32,465 | $23.20 | $753.1K | 0 |
| Apr 30, 2025 | Morris Matthew Shawn | Director | Sell | 10,309 | $23.33 | $240.5K | 0 |
| Apr 30, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 3,445 | $23.33 | $80.4K | 0 |
| Apr 2, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 5,630 | $22.38 | $126.0K | 0 |
| Mar 12, 2025 | Mehrotra Parth | Chief Executive Officer | Sell | 10,514 | $24.03 | $252.7K | 0 |
| Mar 10, 2025 | Fargis Edward C | EVP & General Counsel | Sell | 4,967 | $24.21 | $120.3K | 0 |
| Mar 10, 2025 | Mehrotra Parth | Chief Executive Officer | Sell | 18,934 | $24.21 | $458.4K | 0 |
| Mar 10, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 5,851 | $24.21 | $141.7K | 0 |
| Feb 19, 2025 | Mountcastle David | EVP & Chief Financial Officer | Sell | 100,000 | $25.15 | $2.52M | 157,727-39% |
| Sep 12, 2024 | Mehrotra Parth | Chief Executive Officer | Sell | 135,142 | $18.50 | $2.50M | 247,771-35% |
| May 13, 2024 | Bartrum Thomas | Sell | 1,506 | $17.88 | $26.9K | 102,356 | |
| May 13, 2024 | Mehrotra Parth | Chief Executive Officer | Sell | 13,869 | $17.88 | $248.0K | 247,771 |
| May 13, 2024 | Mountcastle David | EVP & Chief Financial Officer | Sell | 2,232 | $17.88 | $39.9K | 257,727 |
| May 2, 2024 | Bartrum Thomas | Sell | 2,252 | $18.42 | $41.5K | 103,862 | |
| May 2, 2024 | Mehrotra Parth | Chief Executive Officer | Sell | 12,219 | $18.42 | $225.1K | 261,640 |
| May 2, 2024 | Morris Matthew Shawn | Director | Sell | 11,059 | $18.42 | $203.7K | 70,101 |
| May 2, 2024 | Mountcastle David | EVP & Chief Financial Officer | Sell | 2,320 | $18.42 | $42.7K | 259,959 |
| Apr 4, 2024 | Mountcastle David | EVP & Chief Financial Officer | Sell | 3,933 | $17.77 | $69.9K | 262,279 |
| Mar 12, 2024 | Sullivan William M | Director | Sell | 7,515 | $23.03 | $173.1K | 5,445,418 |
PRVA Insiders
Similar Stocks to PRVA
VEEV
Veeva Systems Inc.
$193.40+0.16%
$30.88B
GEHC
GE HealthCare Technologies Inc.
$63.32+2.79%
$29.42B
BTSG
BrightSpring Health Services, Inc. Common Stock
$68.34-1.92%
$14.02B
TEM
Tempus AI, Inc.
$57.63-1.77%
$10.16B
HQY
HealthEquity, Inc.
$95.45+1.01%
$7.89B
HNGE
Hinge Health, Inc.
$86.14-3.49%
$6.96B
TXG
10x Genomics, Inc.
$46.15+0.52%
$5.30B
DOCS
Doximity, Inc.
$22.25+2.06%
$4.17B